Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.
Tanaka S, Matsunami N, Morishima H, Oda N, Takashima T, Noda S, Kashiwagi S, Tauchi Y, Asano Y, Kimura K, Fujioka H, Terasawa R, Kawaguchi K, Ikari A, Morimoto T, Michishita S, Kobayashi T, Sakane J, Nitta T, Sato N, Hokimoto N, Nishida Y, Iwamoto M. Tanaka S, et al. Among authors: kawaguchi k. Cancer Chemother Pharmacol. 2019 Jun;83(6):1099-1104. doi: 10.1007/s00280-019-03836-z. Epub 2019 Apr 8. Cancer Chemother Pharmacol. 2019. PMID: 30963212 Clinical Trial.
A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy.
Tanaka S, Iwamoto M, Kimura K, Takahashi Y, Fujioka H, Sato N, Terasawa R, Kawaguchi K, Ikari A, Tominaga T, Maezawa S, Umezaki N, Matsuda J, Uchiyama K. Tanaka S, et al. Among authors: kawaguchi k. Anticancer Res. 2016 Dec;36(12):6505-6509. doi: 10.21873/anticanres.11250. Anticancer Res. 2016. PMID: 27919974 Clinical Trial.
A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes.
Kimura K, Iwamoto M, Tanaka S, Yamamoto D, Yoshidome K, Ogura H, Terasawa R, Matsunami N, Takahashi Y, Nitta T, Morimoto T, Fujioka H, Kawaguchi K, Uchiyama K. Kimura K, et al. Among authors: kawaguchi k. Cancer Chemother Pharmacol. 2018 May;81(5):923-933. doi: 10.1007/s00280-018-3567-y. Epub 2018 Mar 28. Cancer Chemother Pharmacol. 2018. PMID: 29594360 Clinical Trial.
[A Case of Squamous Cell Carcinoma of the Breast].
Terasawa R, Iwamoto M, Tanaka S, Kimura K, Takahashi Y, Fujioka H, Sato N, Kawaguchi K, Ikari A, Maezawa S, Tominaga T, Matsuda J, Umezaki N, Uchiyama K. Terasawa R, et al. Among authors: kawaguchi k. Gan To Kagaku Ryoho. 2016 Jun;43(6):749-52. Gan To Kagaku Ryoho. 2016. PMID: 27306813 Japanese.
Formation and Segregation of the Ru- and Rh-MgO Solid Solutions.
Okumura K, Sasaki T, Sugihara S, Kawaguchi K, Abdullahi A, Iiyoshi H. Okumura K, et al. Among authors: kawaguchi k. ACS Omega. 2024 Nov 8;9(46):46129-46137. doi: 10.1021/acsomega.4c06472. eCollection 2024 Nov 19. ACS Omega. 2024. PMID: 39583729 Free PMC article.
1,495 results